obesity drug news today october 21 2025 glp-1 Outlook for in 2025: more than a transition year Myths & Facts: GLP-1 Drugs

The UK Association of Anaesthetists published comprehensive multidisciplinary consensus in January 2025, recommending that GLP-1 receptor agonists be continued before surgery with individualised risk assessment [42]

doi: 10.1002/j.1552-4604.1979.tb01646.x [DOI] [PubMed] [Google Scholar] 221.Oberbauer R, Krivanek P, Turnheim K

Your transformation starts here!

Rapid weight loss has been associated with gallbladder-related disorders including cholelithiasis and cholecystitis [67, 68], and these adverse events, while rare, have been observed more with GLP-1RAs compared with placebo in clinical trials [21, 38]

It also ensures the fiber mixes with food content, creating a more homogeneous bolus that moves through the digestive tract more smoothly

Finan, B